Technology in Parkinson's disease: challenges and opportunities AJ Espay, P Bonato, FB Nahab, W Maetzler, JM Dean, J Klucken, ... Movement Disorders 31 (9), 1272-1282, 2016 | 634 | 2016 |
Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter M Vercellino, S Masera, M Lorenzatti, C Condello, A Merola, A Mattioda, ... Journal of Neuropathology & Experimental Neurology 68 (5), 489-502, 2009 | 337 | 2009 |
Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease M Zibetti, A Merola, L Rizzi, V Ricchi, S Angrisano, C Azzaro, CA Artusi, ... Movement Disorders 26 (13), 2327-2334, 2011 | 236 | 2011 |
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? MG Rizzone, A Fasano, A Daniele, M Zibetti, A Merola, L Rizzi, C Piano, ... Parkinsonism & related disorders 20 (4), 376-381, 2014 | 222 | 2014 |
Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and … M Vercellino, A Merola, C Piacentino, B Votta, E Capello, GL Mancardi, ... Journal of Neuropathology & Experimental Neurology 66 (8), 732-739, 2007 | 204 | 2007 |
Parkinson’s disease progression at 30 years: a study of subthalamic deep brain-stimulated patients A Merola, M Zibetti, S Angrisano, L Rizzi, V Ricchi, CA Artusi, M Lanotte, ... Brain 134 (7), 2074-2084, 2011 | 170 | 2011 |
Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological study M Vercellino, B Votta, C Condello, C Piacentino, A Romagnolo, A Merola, ... Journal of neuroimmunology 199 (1-2), 133-141, 2008 | 166 | 2008 |
Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study R Ceravolo, G Cossu, M Bandettini di Poggio, L Santoro, P Barone, ... Movement disorders 28 (10), 1391-1397, 2013 | 163 | 2013 |
Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets AJ Espay, PA LeWitt, RA Hauser, A Merola, M Masellis, AE Lang The Lancet Neurology 15 (9), 954-966, 2016 | 138 | 2016 |
Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study V Ricchi, M Zibetti, S Angrisano, A Merola, N Arduino, CA Artusi, ... Brain stimulation 5 (3), 388-392, 2012 | 134 | 2012 |
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7‐year experience M Zibetti, A Merola, CA Artusi, L Rizzi, S Angrisano, D Reggio, ... European Journal of Neurology 21 (2), 312-318, 2014 | 117 | 2014 |
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease A Merola, A Romagnolo, L Rizzi, MG Rizzone, M Zibetti, M Lanotte, ... Journal of neurology 264, 40-48, 2017 | 87 | 2017 |
Long-term duodenal levodopa infusion in Parkinson’s disease: a 3-year motor and cognitive follow-up study M Zibetti, A Merola, V Ricchi, A Marchisio, CA Artusi, L Rizzi, E Montanaro, ... Journal of Neurology 260, 105-114, 2013 | 87 | 2013 |
Orthostatic hypotension in Parkinson's disease: does it matter if asymptomatic? A Merola, A Romagnolo, M Rosso, JR Lopez-Castellanos, BD Wissel, ... Parkinsonism & related disorders 33, 65-71, 2016 | 82 | 2016 |
Peripheral neuropathy associated with levodopa–carbidopa intestinal infusion: a long‐term prospective assessment A Merola, A Romagnolo, M Zibetti, A Bernardini, D Cocito, L Lopiano European Journal of Neurology 23 (3), 501-509, 2016 | 78 | 2016 |
Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease A Merola, M Zibetti, S Angrisano, L Rizzi, M Lanotte, L Lopiano Movement Disorders 26 (4), 664-670, 2011 | 75 | 2011 |
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study D Cocito, A Merola, E Peci, A Mazzeo, R Fazio, A Francia, P Valentino, ... Journal of neurology 261, 2159-2164, 2014 | 70 | 2014 |
Multiple sclerosis relapses: a multivariable analysis of residual disability determinants M Vercellino, A Romagnolo, A Mattioda, S Masera, C Piacentino, ... Acta Neurologica Scandinavica 119 (2), 126-130, 2009 | 69 | 2009 |
Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease M Zibetti, M Rizzone, A Merola, S Angrisano, L Rizzi, E Montanaro, ... Acta Neurologica Scandinavica 127 (5), e28-e32, 2013 | 67 | 2013 |
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome? A Merola, L Rizzi, M Zibetti, CA Artusi, E Montanaro, S Angrisano, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (5), 552-559, 2014 | 64 | 2014 |